For what concerns anti-TNF drugs, it is unclear whether the greater risk of lymphoma is due to biologic therapy itself, or whether the augmented risk is explained by past or concomitant exposure to immunosuppressants, namely thiopurines (7–10). Here, TNF is linked to lymphoma.